Santen Pharmaceutical Co Ltd 2013 Annual Report with Sustainability Disclosures
Company: Santen Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2013
Type: Annual Report with Sustainability Disclosures
Pages: 84
The report describes Santen’s fiscal 2012 growth, with consolidated net sales reaching ¥119,066 million, and highlights the launch of EYLEA in Japan for wet age-related macular degeneration. It also reports the start of integrated production at its Suzhou plant and continued expansion of its overseas business. The company established a CSR Division and developed CSR promotion fields drawing partly on ISO 26000.
Services
From bulk PDFs to structured indicators and machine-readable documents.